7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,672.38

+276.66

+0.36%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NSE - Delayed Quote INR

Dr. Reddy's Laboratories Limited (DRREDDY.NS)

1,352.00 +7.00 (+0.52%)

At close: October 30 at 3:28:17 PM GMT+5:30

RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales Fall

Zacks 5d ago

RDY

HALO

TGTX
Dr. Reddy's Laboratories Q2 Earnings Call Highlights

MarketBeat 8d ago

TEVA

RDY
Top Stock Reports for Oracle, American Express & Progressive

Zacks 19d ago

ORCL

AXP

PGR
NBIX vs. TEVA: Which Drugmaker Is the Better Investment?

Zacks 2mo ago

TEVA

NBIX

RDY
Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States

Business Wire 2mo ago

RDY

500124
Dr Reddy's Laboratories Ltd (RDY) Q1 2027 Earnings Call Highlights: Navigating Challenges and ...

GuruFocus.com 3mo ago

RDY
Dr. Reddy's Q1 Earnings and Revenues Miss Estimates, Stock Down

Zacks 3mo ago

RDY
Dr. Reddy's Laboratories Q1 Earnings Call Highlights

MarketBeat 3mo ago

RDY

TEVA
Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk

MarketBeat 3mo ago

RDY

TEVA.TA
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F

Business Wire 4mo ago

RDY
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading

PREMIUM
MT Newswires 4mo ago

SIMO

TC

3711.TW
Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States

Business Wire 4mo ago

DRREDDY

RDY

500124

Mobilize your Website

View Site in Mobile | Classic

Share by: